volasertib

Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Fierce Biotech
Tue, 10/15/24 - 10:17 am
Notable Labs
Boehringer Ingelheim
oncology
bankruptcy
volasertib
Notable Labs hopes for success with Boehringer’s failed AML drug
Clinical Trials Arena
Fri, 02/23/24 - 10:35 am
Notable Labs
Boehringer Ingelheim
AML
volasertib
artificial intelligence
Boehringer cancer drug effective in mid-stage trial
Reuters
Tue, 07/8/14 - 10:26 am
Boehringer Ingelheim
acute myeloid leukemia
volasertib
Boehringer Ingelheim to initiate Phase III study in leukemia with its compound volasertib* based on positive Phase II results
Pipeline Review
Tue, 12/11/12 - 11:31 am
Boehringer Ingelheim
leukemia
volasertib
AML
acute myeloid leukemia